Tower Research Capital (TRC)’s Bio Green Med Solution Inc Preferred Stock BGMSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10
Closed -$120 5987
2023
Q2
$120 Hold
10
﹤0.01% 5797
2023
Q1
$0 Hold
10
﹤0.01% 5880
2022
Q4
$0 Buy
+10
New +$90 ﹤0.01% 5957
2017
Q4
Sell
-42
Closed 3599
2017
Q3
$0 Hold
42
﹤0.01% 3826
2017
Q2
$0 Sell
42
-381
-90% -$2.5K ﹤0.01% 2831
2017
Q1
$3K Buy
423
+390
+1,182% +$2.56K ﹤0.01% 2451
2016
Q4
$0 Sell
33
-300
-90% -$1.93K ﹤0.01% 3892
2016
Q3
$2K Sell
333
-45
-12% -$308 ﹤0.01% 3048
2016
Q2
$2K Sell
378
-141
-27% -$757 ﹤0.01% 3874
2016
Q1
$3K Sell
519
-82
-14% -$419 ﹤0.01% 3068
2015
Q4
$2K Buy
+601
New +$2.82K ﹤0.01% 3707

Tower Research Capital (TRC)'s BGMSP Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Bio Green Med Solution Inc Preferred Stock (BGMSP) in Q3 2023, closing a stake of 10 shares — an estimated $120 sold.

Tower Research Capital (TRC) first reported a position in BGMSP in Q4 2015 and held it in 11 quarters. The position peaked at $3K in Q1 2017. 0 funds tracked by Wall St. Rank hold BGMSP as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining Bio Green Med Solution Inc Preferred Stock position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 10 Bio Green Med Solution Inc Preferred Stock shares in Q3 2023, an estimated $120.
  • Tower Research Capital (TRC) first reported a position in Bio Green Med Solution Inc Preferred Stock in Q4 2015 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Bio Green Med Solution Inc Preferred Stock position peaked at $3K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Bio Green Med Solution Inc Preferred Stock as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.